Speaker illustration

Doctor Birgid Gonska

University of Ulm, Ulm (Germany)

Member of:

European Society of Cardiology
EAPCI

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail

This platform is supported by

logo Novo Nordisk